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2Abstract
Pituitary prolactin (PRL) shows an episodic pattern of evolution in mammals, with a slow underlying 
rate (near stasis) and periods of rapid change in some groups. PRL evolution in bats, the second most 
speciose mammalian order, has not previously been studied, and is examined here. Slow basal 
evolution of PRL is seen in some bats, particularly megabats, but in most microbat groups evolution of 
PRL is more rapid. Accelerated evolution of PRL is particularly notable in the family Vespertilionidae, 
where analysis of nonsynonymous and synonymous substitutions indicates that it reflects adaptive 
evolution/positive selection. Remarkably, vespertilionid bats also show a large sequence insertion, of 
variable length, into exon 4 of PRL, giving a protein sequence 18-60 amino acids longer than normal, 
with the longest insertions in bats of the genus Myotis. An equivalent insertion has not been reported in 
PRL of any other vertebrate group. In the 3-dimensional structure of the complex between PRL and the 
extracellular domain (ecd) of its receptor (PRL:PRLR2) the inserted sequence is seen to be introduced 
in the short loop between helices 2 and 3 of PRL; it is far removed from the receptor-binding sites, and 
may not interfere with binding. The ecd of the receptor also shows variable rates of evolution, with a 
higher rate in the Vespertilionidae, but this is much less marked than for the hormone. The distribution 
of substitutions introduced into PRL during vespertilionid evolution appears to be non-random, and this 
and the evidence for positive selection suggests that the rapid evolution and insert sequence 
introduction were associated with a significant change in the biological properties of the hormone.
31. Introduction
Pituitary prolactin (PRL) is a protein hormone that plays an important role in regulating lactation in 
mammals, and a range of other physiological processes both in mammals and non-mammalian 
vertebrates (Clarke and Bern, 1980; Horseman and Gregerson, 2014; Shillingford and Hennighausen, 
2001). PRL is structurally similar to pituitary growth hormone (GH), and is a member of the 4-helical 
bundle cytokine superfamily (Teilum et al., 2005). Like other members of this family PRL acts by 
binding to a membrane-associated receptor with a single transmembrane helical domain. The PRL 
receptor (PRLR) exists at least partly as a preformed homodimer, though binding of PRL may facilitate 
dimerization (Clevinger et al., 2009). Following ligand binding, conformational changes of the receptor 
lead to activation of associated signalling molecules, particularly JAK2 kinase (Clevinger et al., 2009; 
Horseman and Gregerson, 2014). The structure of the extracellular domain (ecd) of the receptor dimer 
bound to PRL (PRL:PRLR2) has been determined by crystallography (Broutin et al., 2010; van 
Agthoven et al., 2010). The conformation of the intracellular domain (icd) is less well understood, 
though recent studies suggest that it may be largely unstructured, providing a scaffold for sequence 
motifs that can bind specific signalling molecules (Bugge et al., 2016; Haxholm et al., 2015).
In mammals, both PRL and GH show an interesting pattern of molecular evolution in which a 
generally very slow basal evolution (near stasis) is punctuated by episodes of rapid change (Forsyth 
and Wallis 2002; Wallis 1981; 1994; 2000; 2009;Wallis et al., 2005).  For GH, one such episode occurs 
within the Chiroptera (bats) (Wallis 2008), but evolution of bat PRL has not been reported. The 
Chiroptera is a large mammalian order, the second most speciose after Rodentia. It shows a number of 
remarkable specializations, including flight, and in some species echolocation and hematophagy 
(feeding on blood). Some bat species have an exceptionally long life-span in relation to size 
(Dammann, 2017)
Recent developments in comparative genomics have led to the availability of complete or partial 
genome sequences for over 100 mammals, including many bats. Transcriptomic data are also available 
for many bat species. Such data make possible the characterization of sequences of PRL and its 
receptor from about 20 bat species, allowing a detailed evaluation of the molecular evolution of the 
4PRL/PRLR pair in this mammalian order. This showed that PRL in Chiroptera shows variable 
evolutionary rates, as in some other mammalian groups, and also, in vespertilionid bats, introduction of 
a long insertion, of a kind unseen in any other vertebrate group.
2. Methods
2.1. Sequences
The sources of the sequence data used in this study are given in Supplementary Table 1.  For a number 
of bat species genomic assemblies are available at www.ncbi.nim.nih.gov, and sequences for PRL and 
PRLR genes were identified using BLAST searches (Altschul et al., 1990) on the appropriate whole-
genome shotgun contig database. In other cases genomic assemblies were not available, but PRL 
and/or PRLR sequences could be obtained from SRA genomic or transcriptomic databases 
(https://trace.ncbi.nlm.nih.gov/Traces/sra/) using BLAST . In these cases, the appropriate 
database/experiment was subjected to a Blast analysis on the SRA website, with a PRL CDS sequence 
(initially from a related species) as Query. The algorithm chosen (megablast, discontiguous megablast 
or blastn) was according to the  extent of difference between template and target. Other parameters 
were the defaults on the sra Blast website, except that the 'number of aligned sequences to display' was 
set to maximum. Formatting options were set to 'flat query-anchored with dots for identities' and line 
length 150. This retrieved sequences that were similar to the Query sequence, aligned/assembled on the 
template (Query), allowing derivation of the full or partial sequence of the target. Gaps were filled by 
'walking up' from adjacent sequence. In all cases sequences were confirmed by searching original 
databases using BLAST. Coding sequences (CDS) were extracted, based on the 5-exon organization of 
the human PRL gene (Truong et al., 1984) and the rabbit PRLR mRNA (Edery et al., 1989), which 
includes 8 coding exons. Examination of bat transcriptomes showed that these are the main forms of 
bat PRL and PRLR mRNA.
2.2 Alignments
CDS sequences for bat PRL and PRLR were assembled using the Mesquite software, version 3.5 
(Maddison and Maddison 2018), and translated to give protein sequences. Sequence alignment was 
carried out manually. Sequences of rabbit, dog and in some cases human PRL and PRLR were included 
5in alignments as outgroups.  Rabbit and dog PRL and PRLR were chosen because they are strongly 
conserved, showing slow evolution and providing a good baseline for assessment of accelerated 
evolution in other groups.  Human PRL and PRLR were included in the sequence alignments shown, 
because of the extensive structural and other work carried out on them, but were not used in the codeml 
analyses.   Signal peptide position was assigned by comparison with PRL and PRLR precursor 
sequences from other species (including human).
2.3 Phylogenies
Bat phylogenies were based on Agnarsson et al. (2011) and Amador et al. (2018). Phylogenies obtained 
using the PRL and PRLR sequence data generally agreed well with these.
2.4. Sequence analysis - evolutionary rates
To analyse evolutionary rates for bat PRL and PRLR CDS sequences, the codeml programme 
in the paml package (Phylogenetic Analysis by Maximum Likelihood; Yang, 2007) was used 
to determine the ratio (dN/dS) of nonsynonymous substitutions (altering amino acid sequence) 
to synonymous substitutions (silent). For most proteins dN/dS is low, as purifying selection 
maintains functional sequence. For a sequence without specific function dN/dS approaches 1.0, 
the neutral rate of evolution. A dN/dS value significantly greater than 1.0 indicates that the 
sequence is undergoing rapid adaptive evolution due to positive selection, but a value lower 
than 1.0 does not necessarily rule out adaptive evolution (Nei and Gojobori, 1986).
CDS sequence alignments corresponding to all or subregions of the PRL and PRLR mRNAs 
were analysed using the codeml method (Yang, 2007), with a defined phylogenetic tree based 
on previously-described bat phylogenies (see Section 2.3). Variation in evolutionary rates for 
different branches in the phylogeny was investigated using the branch models in codeml 
(Yang, 1998; Yang and Nielsen, 1998). Positive selection at specific sites across branches was 
studied using the branch site models (Yang et al., 2005, Zhang et al., 2005). The likelihood 
ratio test (LRT) was used to test significance of differences between dN/dS ratios (Yang, 
2007).
62.5. 3-dimensional  models
Homology models for bat PRL:PRLR2 complexes were constructed using the SWISS-MODEL server 
at https://swissmodel.expasy.org (Waterhouse et al., 2018) with the structure of human PRL bound to 
two molecules of rat PRLR (3npz; van Agthoven et al., 2010) as template.  Models were visualized and 
marked up using PyMol (The PyMOL Molecular Graphics System, Version 1.8.7, Schrödinger, LLC).
2.6. Transcription
Expression of bat PRL and PRLR in a variety of tissues was assessed by examining transcriptomes 
available in the SRA database, using BLAST. 
3. Results and Discussion
3.1. Bat prolactin sequences
Complete PRL sequences (CDS and protein) were obtained for 21 bat species, representing 8 bat 
families, and both megabats and microbats (Supplementary Table 1).  In many species evidence was 
seen in the sequence data for modest allelic polymorphism, but in no case was there evidence for gene 
duplication or an extended family of PRL-like genes as seen in rodents and ruminants (Carter, 2012; 
Forsyth and Wallis, 2002).
An alignment of bat PRL sequences is shown in Fig. 1. Considerable sequence variation between 
species is apparent, with megabats being much less variable than microbats. However, the most 
striking aspect of the sequence comparison is the insertion of an additional sequence in vespertilionid 
bats. This occurs within exon 4, and clearly reflects an insertion of additional coding sequence into this 
exon rather than introduction of an additional intron, because the characteristic sequence motif at the 
start and end of an intron (GT....AG), required for processing, is not present. Furthermore, in several 
species analysis of transcriptomic databases showed that the inserted sequence is found in mRNA (see 
section 3.6).  The length of the inserted sequence varies from 18 to 60 amino acids (aa), with the longer 
sequences (>18 aa) found in Myotis spp. Apart from this substantial insert in exon 4, the mature 
(excluding signal peptide) bat PRL sequences contain no additional insertions or deletions (indels). A 
substantial insertion of the kind seen in vespertilionid bats does not appear to have been reported for 
7PRL from any other mammalian or nonmammalian species (Ocampo Daza and Larhammar, 2018; 
Wallis, 2000). The nature of the inserted sequence is considered in detail below. It should be noted that 
for four of the vespertilionid species (Myotis brandtii, M. davidii, M. lucifugus and Eptesicus fuscus) 
predicted PRL CDS sequences are given in GenBank entries (respectively XM_005869979, 
XM_006757283, XM_006093744 and XM_008146068) in which the inserted sequence is interpreted 
as an intron and excluded. Reasons for thinking that this is an incorrect interpretation are given above. 
Revised prolactin CDS sequences for these four species have been deposited in the Third Party 
Annotation Section of the DDBJ/ENA/GenBank databases under the accession numbers TPA: 
BK010631-BK010634.
3.2. Variable rate of evolution of prolactin in bats
The bat PRL sequence alignment suggested variable rates of evolution (Fig. 1). This was examined 
further using the codeml programme and the corresponding CDS alignment for mature PRL, excluding 
the inserted sequence (Supplementary Fig.1). Analysis allowing assignment of dN/dS values 
independently to each branch indicated a markedly variable evolutionary rate (Fig. 2), with very 
variable branch lengths and dN/dS values. Application of the likelihood ratio test confirmed significant 
variation between branches and clades (Fig. 2). The overall rate of PRL evolution in megabats is very 
low (dN/dS = 0.062), similar to that for the outgroups (dog and rabbit, selected as having shown low 
evolutionary rate previously, dN/dS = 0.049). In most microbat groups the rate of PRL evolution 
(dN/dS) is much higher, but very variable. Thus it falls back to the slow rate seen for megabats in 
Miniopterus natalensis (dN/dS = 0.039) and in some cases markedly different dN/dS ratios were seen 
for closely related species pairs (e.g. Desmodus rotundus, dN/dS = 0.204/Carollia brevicauda, dN/dS = 
0.843, Fig. 2). For some branches dN/dS > 1.0, but not significantly so, given the need for multiple test 
correction. Therefore, the accelerated evolution could not be shown formally to be due to positive 
selection rather than a loss of biological function (relaxed selection), though the latter seems unlikely 
on biological grounds.
A more discriminating test for positive selection is the branch-site method in codeml, which tests for 
variation in evolutionary rates between specific sites on designated branches (Zhang et al., 2005). 
Applying this method to the bat PRL alignment, positive selection was established for the 
8vespertilionid clade (dN/dS = 1.90; P<0.01; 75 sites identified as showing positive selection), and also 
for the Myotis clade (dN/dS = 3.01; P<0.05; 41 sites identified as showing positive selection) 
(Supplementary Table 2). Thus the accelerated evolution in these groups at least was a consequence of 
positive selection rather than relaxed selection. 
3.3. The inserted sequence in vespertilionid bats
As indicated, the most striking novel feature observed in this study of bat PRL was the introduction of 
an additional sequence into the 4th exon in vespertilionid bats (Fig.1). The location of this insertion 
corresponds to the short loop between helices 3 and 4 in the 3D structure (see below). The insertion 
varies in length, from 18 aas in Eptesicus, Pipistrellus and Lasiurus, to 36-60 aas in the 4 Myotis 
species studied. It appears to have arisen as a series of internal duplications of an 18 nucleotide (nt) (6-
aa) sequence, the original 6 aa sequence corresponding almost exactly to the short loop between helices 
3 and 4. This repeating 6-aa unit is seen in each of the inserted regions (Fig. 3), though partially 
masked by the large number of substitutions that have been introduced subsequently. The inserted 
sequence could not be included in the codeml analysis because it varies in length between species. 
However, comparison of sequences of equivalent length shows that it is more variable than the adjacent 
sequence, suggesting that it too may be evolving under positive selection rather than relaxed selection.
The long insertion seen in vespertilionid bat PRL has no equivalent in any other species, and no 
apparent similarity could  be detected with any other protein sequence. Its introduction appears to 
reflect a mechanism by which a novel repeat protein sequence can be built up rapidly during the course 
of evolution. Its function is not clear, but the observation that it and the rest of the PRL sequence in 
Vespertilionidae appears to be subject to positive selection suggests that it does have a specific, 
possibly novel, role.  The short loop between helices 3 and 4 is not close to either receptor-binding site 
on PRL, and extending the length of this loop may not necessarily affect receptor binding (see below).
3.4. Bat prolactin receptor
The bat PRLR was investigated in order to assess to what extent the evolutionary changes seen in the 
hormone are reflected in changes in the receptor. Coevolution of PRL and its receptor has been 
reported in some other mammalian groups (Li et al., 2005)
9Complete PRLR sequences were derived from genomic and transcriptomic databases for 19 bat species  
(Supplementary Table 1). For not all species were both PRL and PRLR sequences obtained, due to 
incomplete data. The PRLR sequences are aligned in Fig. 4.  In many cases modest allelic 
polymorphism was observed, but in none was there evidence for duplication of the PRLR gene. As has 
been reported for other mammalian PRLR genes (Edery et al., 1989; Hu et al., 1999), the coding 
sequence was divided into 8 exons separated by 7 introns.  The protein sequence is divided into 4 
distinct domains, signal peptide, extracellular domain (ecd), single transmembrane domain (tmd) and 
intracellular domain (icd) (Fig. 4). Since these domains have quite distinct functions, and little 
structural interaction, they were considered separately for the evolutionary analysis with emphasis on 
the ecd and icd since signal peptide and tmd are quite short.
The ecd alignment (Fig. 4) shows that there is considerable variation between ecd sequences, with 
megabat sequences being less divergent than those of microbats, though this distinction is less marked 
than for PRL. The phylogenetic trees of Fig. 5 confirm this. Analysis using codeml (of the ecd CDS 
alignment given in Supplementary Fig. 2) gave an overall dN/dS of 0.371, and showed significant rate 
variation along branches (P<0.01, LRT), though this is less marked than seen for PRL. The rate of 
evolution for ecd in megabats is lower than that in microbats (Fig. 5), but in contrast to PRL the 
difference is not significant. Only for Vespertilionidae was the rate of evolution (dN/dS) significantly 
elevated (Fig. 5), but dN/dS did not exceed 1.0, so positive selection rather than relaxed selection could 
not be established.
The icd alignment (Fig. 4) shows substantial variation between species, but the pattern of this differs 
markedly from that seen for the ecd. Analysis using codeml (of the icd CDS alignment given in 
Supplementary Fig. 3) showed a high overall dN/dS (0.478), but no significant rate variation between 
lineages (P > 0.1; LRT). Scrutiny of the alignment suggested the presence of regions within the icd that 
were strongly conserved, and others that were very variable. The most notable conserved region is that 
immediately following the tmd, which contains box 1 and box 2, conserved motifs found in many 
cytokine receptors and required for biological function (DaSilva et al., 1994). Box 1 is crucial for 
association with protein kinase JAK2. Also fully conserved are 4 tyrosine residues in the C-terminal 
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half of the icd, likely to be subject to phosphorylation providing docking sites for other signalling 
molecules. These are the only Tyr residues completely conserved in the icd; short sequences around 
them are also strongly conserved. Haxholm et al. (2015) have proposed that the icd is largely 
unstructured, but includes 5 regions forming temporary helices (shown in Fig. 4). The first 2 of these 
(THD1-THD2) are included in the region close to the tmd, and are therefore strongly conserved. THD3 
partially overlaps this region and is less conserved, and THD4 and THD5 are much less conserved. 
Haxholm et al. (2015) have also obtained evidence for three regions of the icd that associate with the 
plasma membrane (LD1-LD3); LD1 is included in the region close to the TMD, and is strongly 
conserved; LD2 and LD3 are very variable (Fig. 4).  The pattern of variation seen in the icd accords 
with the view (Haxholm et al., 2015; Bugge et al., 2016) that the icd shows an open, relatively 
unstructured conformation, acting as a scaffold for binding of signalling molecules such as JAK2 
kinase and STAT5. The conserved regions would then be the conserved specific binding sites for such 
molecules, while the regions between would act as spacers, with little requirement for specific, 
conserved sequence. It is also notable in this context that frequent indels are seen in the icd sequence 
(13 in the alignment of Fig. 4), in contrast to the complete lack of such indels in the ecd
3.5. Structural models of the PRL:PRLR2 complex
Several 3D structures are available for PRL bound to the ecd of its receptor, including at least 2 for the 
putatively biologically active heterotrimer, PRL:PRLR2 (Broutin et al., 2010; van Agthoven et al., 
2010). The structure of the complex between human PRL and the rat PRLR ecd (van Agthoven et al., 
2010) was used as the template for molecular modelling using SWISS-MODEL, to give homology 
models for several bat PRL:PRLR2 complexes. Three of these are illustrated in Fig. 6. In all cases the 
model structures obtained matched the template closely, and Ramachandran plots were of a quality 
similar to that of the template.
Of particular interest is the location of the insert sequence seen in vespertlionid bat PRL. For PRL of 
the megabat Pteropus alecto, for which there is no inserted sequence, the short loop between helices 2 
and 3 is seen to be well removed from the receptor binding sites (Fig. 6 top).  For Eptesicus fuscus, 
with an inserted sequence of 18 residues, (Fig. 6 middle) and Myotis brandtii, with an insert of 60 
residues, (Fig. 6 bottom) the inserts in the short loop are again seen to be far removed from the receptor 
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binding sites, and unlikely to interfere with receptor binding. It should be noted, however, that 
structures of the inserted sequences are unlikely to be very accurate, given that there is no equivalent to 
them in the template. The main conclusion from this structural study is that the insertions occur in a 
region compatible with retention of receptor binding.
The structural models also allow assessment of substitutions occurring during the course of evolution 
in relation to their positioning within the structure. The distribution of substitutions appeared to be non-
random. Thus for the Myotis clade, the branch-site analysis (see above) identified 41 residues in PRL 
that appear to be subject to positive selection; these were distributed mainly in two regions, at the end 
of PRL distal from the receptor-binding sites and close to the inserted sequence, and in binding site 2 
(Fig.7A and B). In the other vespertilionids, however, concentration of substitutions in these regions 
was not seen, and a large proportion of substitutions was seen at the end of PRL closest to the binding 
sites (Fig.7C and D).  Such non-random distribution of substitutions accords with the view that PRL in 
vespertilionids is evolving under positive selection, and suggests that the specific adaptations involved 
vary among groups. In the PRLR ecd the distribution of substitutions occurred widely across the 
structure, with no concentration in specific regions. 
3.6 Transcription of PRL and PRLR
Transcriptomic data is available for a number of bat species (summarized in Supplementary Table 1). 
No transcriptomes for pituitary gland (the main site for PRL synthesis) or placenta (the site for 
synthesis of PRL-like hormones in some mammalian groups) were specifically available. However, 
transcriptomes for brain from a number of species were available; in some of these PRL transcription 
was quite high, in others it was low, which may reflect varying inclusion of anterior pituitary gland in 
the brain material used.  High levels of PRL transcription were also seen in trigeminal nuclei (in 
Desmodus rotundus and Carollia brevicauda), which has been shown to be a site of high PRL 
expression in rats (Diogenes et al., 2006), and in cochlea (Rhinolophus macrotis, Hipposideros 
armiger), a site of PRL expression in female mice (Marano et al., 2013). PRL transcription at low 
levels was seen in a number of peripheral tissues, as expected from studies on other mammals (Ben-
Jonathan et al., 1996), but in none of these cases was a complete sequence derived. Transcriptomes 
confirmed the presence of the insertion sequence in PRL mRNA from several vespertilionid species, 
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and its absence in many other bat species. Evidence for alternative splicing of PRL mRNA precursor 
was seen in three species (Aselliscus stoliczkanus, H. armiger, R.macrotis), with inclusion or exclusion 
of one codon (GCA, encoding Ala) at the exon1/exon2 junction (Supplementary Table 1B).
Moderate to high expression of PRLR was seen in many bat tissues, from a considerable number of 
species, with highest abundance observed in liver, brain, cochlea, sub-mandibular gland and testis. 
Some evidence was seen for alternative splicing at the first splice junction between coding exons, with 
a variant with 5 nt excluded at this site, and another including 60 nt of the intron.  The significance of 
these variants is not clear, but they were much less abundant that the main form, and any resulting 
variation at the protein level would probably only involve the signal peptide. Alternative splicing 
involving additional upstream non-coding exons was not investigated.
3.7 Conclusions
PRL evolution in Chiroptera shows episodic evolution, but the nature of this is rather different from 
that seen in several other mammalian groups, including primates and cetartiodactyls, where a single 
episode of rapid change contrasts with an otherwise very slow basal evolution (Wallis, 2000; Wallis et 
al., 2005). In Chiroptera very slow evolution is seen in megabats, but rapid evolution appears to be 
sustained throughout microbats, with a few exceptions such as the lineage leading to Miniopterus. The 
rapid evolution is particularly marked in the Vespertilionidae, the largest bat family, with a world-wide 
distribution, where it accompanies the insertion of an additional peptide sequence of 18-60 amino acids 
in the short loop between helices 2 and 3. On some branches within Vespertilionidae dN/dS > 1, 
suggesting selective, adaptive evolution. Branch-site analysis confirmed adaptive evolution within 
Vespertilionidae and identified specific residues likely to be subject to positive selection. Notably, 
these sites show an apparently non-random distribution in the 3D structure. The very rapid evolution of 
PRL in Vespertilionidae is emphasized by comparison with the sequence of a reptilian PRL (alligator; 
Noso et al., 1992; Wallis 2000). The sequence of a megabat PRL (Pteropus alecto) is more similar to 
PRL of the alligator (Alligator mississippiensis) than to that of a vespertilionid bat (Myotis lucifugus) 
(Fig. 1), although lineages leading to microbats and megabats diverged 60-65 million years ago (MYA) 
(Amador et al., 2018) while those leading to reptiles and mammals diverged about 310 MYA (Kumar 
and Hedges, 1998).
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The inserted sequence in PRL in vespertilionids also appears to be undergoing rapid adaptive evolution 
though quantitative evaluation is difficult because of the variable length of the inserted sequences. The 
insert sequence shows a repetitive structure, reflecting internal duplication of the 6 amino acids of the 
short loop. Such an insert is not seen in PRL from other mammalian groups, or indeed other 
vertebrates, and appears to illustrate the origin and evolution of a completely novel sequence.  
Elucidation of the function associated with the insert will require physiological and biological studies;  
its location far-removed from the receptor-binding sites suggests that it may not affect receptor-
binding.
The episodic evolution seen in bat PRL is reflected, though to a lesser extent, in the PRLR ecd, 
suggesting coevolution of PRL and its receptor as has been detected in some other groups (Li et al., 
2005).  The evolution of the icd shows a completely different  pattern of evolution, with no evidence 
for variable rates of evolution on differing bat lineages, but marked variation in sequence conservation 
along the sequence, with strongly conserved regions alternating with very variable ones.  It seems 
likely that this reflects the rather open structure of the ecd, providing strongly conserved binding sites 
for intracellular signalling molecules, joined by very variable linker regions.
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Figure Legends
Fig. 1. Alignment of bat prolactin sequences. Sequences of rabbit, human, dog and alligator PRLs are 
included as outgroups. The sequence of rabbit PRL is shown in full on the top line. For sequences 
below this,     . indicates  a residue identical to rabbit, - indicates a gap.  The signal peptide is shaded 
grey and the position of the inserted sequence found in vespertilionid bats is indicated. Numbers at the 
right indicate differences from rabbit for: (a) signal peptide, (b) mature protein, (c) total (excluding 
inserted sequences). Location of exons in the corresponding nucleotide sequence is indicated on the 
bottom line. Abbreviations for species names: Ocu, Oryctolagus cuniculus; Hsa, Homo sapiens; Cfa, 
Canis familiaris; Pal, Pteropus alecto; Pva, Pteropus vampyrus; Ast, Aselliscus stoliczkanus; Ehe, 
Eidolon helvum; Rae, Rosettus aegypticus; Mly, Megaderma lyra; Hsi, Hipposideros armiger; Rfe, 
Rhinolophus ferrumequinum; Rsi, Rhinolophus sinicus; Rma, Rhinolophus macrotis; Mna, Miniopterus 
natalensis; Ppa, Pteronotus parnellii; Dro, Desmodus rotundus; Cbr, Corollia brevicauda; Efu, 
Eptesicus fuscus; Ppy, Pipistrellus pygmaeus; Lbo, Lasiurus borealis; Mlu, Myotis lucifugus; Mbr, 
Myotis brandtii; Mru, Myotis rufonige; Mda, Myotis davidii; Ami, Alligator mississippiensis. 
Fig. 2. Phylogenetic trees for bat prolactin. Based on analysis of an alignment of CDS sequences for 
mature PRL (excluding signal peptides and inserted sequences in Vespertilionidae) using codeml and a 
defined tree. Trees based on synonymous sites (dS, top) and nonsynonymous sites (dN, bottom) are 
shown. Numbers at the right-hand side of the dN tree are dN/dS values for the clades indicated. 
Difference from the mean dN/dS value for the tree (0.356) are shown as * P<0.05, *** P<0.001 
(likelihood ratio test). Scale bars indicate nucleotide substitutions/codon. Abbreviations for species 
names are as for Fig. 1.
Fig. 3. Hexapeptide repeats within the inserted sequences in vespertilionid bat prolactin. For each 
species, the top sequence is the hexapeptide preceding the inserted sequence. Sequences below this 
represent the insert broken into hexapeptides. For full sequences of the inserts see Fig. 1.
Fig. 4. Alignment of bat prolactin receptor sequences. Sequences of rabbit, human and dog PRLRs are 
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included as outgroups. The sequence of rabbit PRLR is shown in full on the top line. For sequences 
below this, . indicates  a residue identical to rabbit, - indicates a gap.  The signal peptide and 
transmembrane domain are shaded grey. Potential functional components of the icd are indicated: box 
1 and box 2, TDH1-5, LD1-3. Numbers at the right indicate differences from rabbit (including indels) 
for: (a) signal peptide, (b) ecd, (c) tmd, (d) icd (e) total. Abbreviations for species names are as for Fig. 
1 plus Mle, Murina leucogaster.
Fig. 5. Phylogenetic trees for bat prolactin receptor ecd. Based on analysis of an alignment of CDS 
sequences using codeml and a defined tree. Trees based on synonymous sites (dS, top) and 
nonsynonymous sites (dN, bottom) are shown. Numbers at the right-hand side of the dN tree are dN/dS 
values for the clades indicated. Difference from the mean dN/dS value for the tree (0.371) are shown as 
** P<0.01, *** P<0.001 (likelihood ratio test). Scale bars indicate nucleotide substitutions/codon. 
Abbreviations for species names are as for Figs. 1 and 4.
Fig. 6. Molecular models for PRL:PRLR2 from 3 bat species. In each case, the model was constructed 
using the SWISS-MODEL homology modelling server, with the human PRL:rat RPRL2 structure 
(3npz) as template. The view is looking down towards the membrane. PRL is in green except for the 
loop between helices 2 and 3 plus inserted sequence which is in blue, PRLR ecds are in cyan and 
magenta; other receptor domains are not included.
Fig. 7. Distribution of substitutions within the homology models of bat prolactin. The substitutions 
identified as potentially involving positive selection were mapped onto the PRL:PRLR2 homology 
models for Myotis lucifugus (A and B; substitutions in Myotis clade) or Eptesicus fuscus (C and D; 
substitutions in Vespertilionidae excluding Myotis). A and C are viewed looking down, towards the 
membrane, B and D are viewed looking up, away from the membrane. The PRLR ecd chains are 
shown in cartoon format, chain B cyan, chain C magenta. PRL is shown in space filling format, blue,  
with the loop between helices 3 and 4 (including insert sequence) shown in dark blue. PRL residues 
identified as potentially positively selected in the branch-sites analysis (excluding inserted sequence) 
are shown as orange (residues in binding site 1), red (residues in binding site 2), purple (in binding sites 
1 and 2) or yellow (other residues).
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A) Branch-site analysis for Myotis clade
lnL = -3954.894481
dN/dS (w) for site classes (K=4)
site class             0        1       2a       2b
proportion       0.50832  0.18266  0.22734  0.08169
background w     0.16319  1.00000  0.16319  1.00000
foreground w     0.16319  1.00000  3.01081  3.01081
Bayes Empirical Bayes (BEB) analysis 
Positive sites for foreground lineages Prob(w>1):
     3 I 0.648
     6 S 0.715
     7 G 0.712
    14 S 0.947
    17 D 0.640
    21 R 0.794
    24 I 0.700
    27 H 0.659
    29 I 0.736
    31 K 0.612
    38 N 0.859
    41 D 0.630
    43 R 0.668
    47 G 0.975*
    49 G 0.948
    51 I 0.732
    53 K 0.744
    74 Q 0.830
    84 V 0.564
    89 R 0.746
   100 T 0.564
   104 G 0.980*
   105 M 0.733
   106 Q 0.722
   109 P 0.707
   111 A 0.557
   121 E 0.919
   123 N 0.672
   136 Q 0.580
   144 N 0.764
   147 Y 0.886
   154 P 0.810
   155 S 0.696
   157 Q 0.797
   158 M 0.690
   161 E 0.780
   162 D 0.684
   168 F 0.754
   170 N 0.999**
   172 L 0.725
   188 L 0.959*
For Null (w constrained to 1.0)
lnL = -3959.046770
dN/dS (w) for site classes (K=4)
site class             0        1       2a       2b
proportion       0.35595  0.13292  0.37216  0.13897
background w     0.15773  1.00000  0.15773  1.00000
foreground w     0.15773  1.00000  1.00000  1.00000
LRT test:
2xΔlnL = 8.32; 2 degrees of freedom; P<0.05




B) Branch-site analysis for Vespertilionidae clade
lnL = -3939.697653
dN/dS (w) for site classes (K=4)
site class             0        1       2a       2b
proportion       0.54940  0.07893  0.32498  0.04669
background w     0.16195  1.00000  0.16195  1.00000
foreground w     0.16195  1.00000  1.89670  1.89670
Bayes Empirical Bayes (BEB) analysis 
Positive sites for foreground lineages Prob(w>1):
     1 L 0.796
     3 I 0.911
     6 S 0.816
     7 G 0.949
     8 A 0.957*
     9 V 0.973*
    10 N 0.982*
    12 Q 0.760
    14 S 0.989*
    17 D 0.991**
    21 R 0.693
    27 H 0.890
    29 I 0.510
    34 S 0.645
    38 N 0.972*
    41 D 0.540
    42 K 0.574
    43 R 0.649
    45 T 0.560
    46 Q 0.945
    47 G 0.910
    49 G 0.889
    51 I 0.631
    53 K 0.602
    54 A 0.544
    57 S 0.529
    62 S 0.808
    63 L 0.898
    74 Q 0.734
    75 I 0.584
    76 H 0.603
    77 H 0.909
    83 M 0.681
    84 V 0.875
    86 R 0.559
    89 R 0.556
    97 H 0.611
   100 T 0.535
   104 G 0.951*
   105 M 0.987*
   106 Q 0.657
   108 A 0.810
   109 P 0.660
   110 D 0.610
   111 A 0.892
   114 S 0.957*
   121 E 0.875
   127 L 0.982*
   132 K 0.946
   135 G 0.996**
   136 Q 0.900
   139 P 0.994**
   142 K 0.694
   143 E 0.961*
   144 N 0.593
   146 I 0.898
   147 Y 0.700
   148 S 0.672
   149 V 0.987*
   151 S 0.761
   153 L 0.653
   154 P 0.745
   155 S 0.670
   157 Q 0.670
   158 M 0.679
   161 E 0.635
   166 F 0.615
   168 F 0.952*
   170 N 0.993**
   172 L 0.551
   173 H 0.619
   182 I 0.623
   188 L 0.902
   192 R 0.742
   196 D 0.553
For Null (w constrained to 1.0)
lnL = -3945.680906
dN/dS (w) for site classes (K=4)
site class             0        1       2a       2b
proportion       0.47101  0.07267  0.39532  0.06100
background w     0.15095  1.00000  0.15095  1.00000
foreground w     0.15095  1.00000  1.00000  1.00000
LRT test:
2xΔlnL = 11.96; 2 degrees of freedom; P<0.01
tree for this analysis:
(Ocu,Cfa,(((Rae,(Ehe,(Pal,Pva))),(Mly,((Har,Ast),(Rfe,(Rsi,Rma)))
)),((Ppa,(Dro,Cbr)),(Mna,((Lbo,(Efu,Ppy)),((Mru,Mda),(Mlu,Mbr)))$
1))));
